Académique Documents
Professionnel Documents
Culture Documents
Ectoparasites continue to be a common cause of skin disease throughout the world. The present article dissects
the epidemiological profile and treatment of both Sarcoptes scabiei variant hominis and pediculosis pubis.
SCABIES
Treatment
Permethrin 5% (60 g) cream
Lindane 1% (60 mL)
15.9940.79a
2.7514.37b
Lotion
Shampoo
c
Crotamiton
85.99125.97a
d
62.79
12.7026.62
109.55143.99
6.7527.52b
Ivermectin (3 mg)g
103.99116.99a
Data (from 2006) are from Drugstore.com [26], CVS.com [27], and Kerr Drug (North Carolina) [28].
Data from 1999 Drug Topics Red Book [29].
10% cream (croton oil [5 g]) or 10% lotion.
Data (from 2006) are from GetCanadianDrugs.com [30].
Not commercially available in the United States.
Sulfur 6% or precipitated sulfur powder (500 g).
Twenty tablets.
Treatment
Permethrin 1% cre`me rinse (2 oz)
Lindane 1% shampoo
Average
wholesale price, US$
7.67a
3.0014.72b
5.5 oz (mousse)
9.20
b
c
2 oz (shampoo)
PEDICULOSIS PUBIS
Introduction and methods. Lice are blood-sucking insects
that have no free-living stage in their life cycle [58]. Lice primarily infest the head (Pediculus humanus var. capitis), the body
(Pediculus humanus var. corporis), or the pubic region (Phthirus
pubis). Head lice are the most common lice. In the present
article, we will summarize key characteristics of pediculosis
pubis and update the current approaches to diagnosis and treatment. A search was conducted of the English-language literature
published between 1 June 2000 and 1 January 2006. A Medline
search was conducted using the terms pubic lice, Phthirus
pubis, pediculosis, pediculosis pubis, permethrin, and
lindane. AIDSline was searched, omitting Medline listings,
by use of the terms Phthirus pubis, pediculosis, and pediculosis pubis. Abstracts from meetings of the Infectious Diseases Society of America and the International Society of Sexually Transmitted Diseases Research, as well as from the joint
meetings of the American Sexually Transmitted Diseases Association and the Medical Society of Venereal Diseases, were
reviewed for contributory work. For each study, the following
characteristics were defined: study dosing, study population,
DISCUSSION
Ectoparasites continue to be a common cause of skin disease
throughout the world. Topical agents are generally effective in
the management of extoparasites but are accompanied by
sometimes-serious adverse effects, and resistance to several
agents has been documented. Ivermectin is a new oral mode
of treatment for scabies and may hold particular promise in
the treatment of epidemic or severe scabies. Lindane is no
S158 CID 2007:44 (Suppl 3) Leone
References
1. Walker GJ, Johnstone PW. Interventions for treating scabies. Cochrane
Database Syst Rev 2000; (3):CD000320.
2. Wendel K, Rompalo A. Scabies and pediculosis pubis: an update of
treatment regimens and general review. Clin Infect Dis 2002; 35(Suppl
2):S14651.
3. Mathisen GE. Of mites and menlessons in scabies for the infectious
diseases clinician [editorial; comment]. Clin Infect Dis 1998; 27:6468.
4. Burkhart CG, Burkhart CN, Burkhart KM. An epidemiologic and therapeutic reassessment of scabies. Cutis 2000; 65:23340.
5. Mimouni D, Gdalevich M, Mimouni FB, Haviv J, Ashkenazi I. The
epidemiologic trends of scabies among Israeli soldiers: a 28-year followup. Int J Dermatol 1998; 37:5867.
6. Christophersen J. The epidemiology of scabies in Denmark, 1900 to
1975. Arch Dermatol 1978; 114:74750.
7. Kimchi N, Green MS, Stone D. Epidemiologic characteristics of scabies
in the Israel Defense Force. Int J Dermatol 1989; 28:1802.
8. Downs AM, Harvey I, Kennedy CT. The epidemiology of head lice
and scabies in the UK. Epidemiol Infect 1999; 122:4717.
9. Holness DL, DeKoven JG, Nethercott JR. Scabies in chronic health
care institutions. Arch Dermatol 1992; 128:125760.
10. Alberici F, Pagani L, Ratti G, Viale P. Ivermectin alone or in combination with benzyl benzoate in the treatment of human immunodeficiency virusassociated scabies. Br J Dermatol 2000; 142:96972.
11. Chosidow O. Scabies and pediculosis. Lancet 2000; 355:81926.
12. Walton SF, McBroom J, Mathews JD, Kemp DJ, Currie BJ. Crusted
scabies: a molecular analysis of Sarcoptes scabiei variety hominis populations from patients with repeated infestations. Clin Infect Dis
1999; 29:122630.
13. Kemp DJ, Walton SF, Harumal P, Currie BJ. The scourge of scabies.
Biologist (London) 2002; 49:1924.
14. Hashimoto K, Fujiwara K, Punwaney J, et al. Post-scabetic nodules: a
lymphohistiocytic reaction rich in indeterminate cells. J Dermatol
2000; 27:18194.
15. Currie B, Huffam S, OBrien D, Walton S. Ivermectin for scabies [letter;
comment]. Lancet 1997; 350:1551.
16. Adjei O, Brenya RC. Secondary bacterial infection in Ghanaian patients
with scabies. East Afr Med J 1997; 74:72931.
17. Jarrett P, Snow J. Scabies presenting as a necrotizing vasculitis in the
presence of lupus anticoagulant. Br J Dermatol 1998; 139:7013.
18. Valks R, Buezo GF, Dauden E. Scabies and leukocytoclastic vasculitis
in an HIV-seropositive man [letter]. Int J Dermatol 1996; 35:6056.
19. Dieng MT, Ndiaye B, Ndiaye AM. Scabies complicated by acute glomerulonephritis in children: 114 cases observed in two years in a pediatric
service in Dakar [in French]. Dakar Med 1998; 43:2014.
20. Micali G, Lacarrubba F, Lo GG. Scraping versus videodermatoscopy
for the diagnosis of scabies: a comparative study [letter]. Acta Derm
Venereol 1999; 79:396.
46.
47.
48.
49.
50.
51.
52.
53.
54.
55.
56.
57.
58.
59.
60.
61.
62.
63.
64.
65.
66.